Sedative, hypnotic or anxiolytic use, unspecified with withdrawal, unspecified
ICD-10 F13.939 is a billable code used to indicate a diagnosis of sedative, hypnotic or anxiolytic use, unspecified with withdrawal, unspecified.
F13.939 refers to a condition characterized by the use of sedative, hypnotic, or anxiolytic substances leading to withdrawal symptoms. This code is used when a patient exhibits signs of withdrawal from these substances but does not specify the exact substance or the severity of the withdrawal. Withdrawal symptoms can include anxiety, tremors, insomnia, and in severe cases, seizures. The diagnosis is crucial as it indicates a substance use disorder that requires intervention. Treatment typically involves a medically supervised detoxification process, followed by rehabilitation programs that may include cognitive-behavioral therapy, support groups, and medication-assisted treatment. Accurate coding is essential for appropriate treatment planning and insurance reimbursement, as it reflects the complexity of the patient's condition and the need for comprehensive care.
Detailed history of substance use, withdrawal symptoms, and treatment plan.
Patients presenting with withdrawal symptoms after cessation of sedative use.
Consideration of co-occurring mental health disorders and the need for integrated treatment.
Comprehensive psychiatric evaluation, including mental status examination and history of substance use.
Patients with anxiety disorders who misuse anxiolytics.
Assessment of the impact of withdrawal on mental health and potential for relapse.
Used when assessing a patient for withdrawal symptoms.
Document the assessment findings and treatment plan.
Addiction specialists should ensure comprehensive evaluations.
Common withdrawal symptoms include anxiety, tremors, insomnia, irritability, and in severe cases, seizures.
